THE DIFFERENCE OF HEMOGLOBIN LEVELS IN BREAST CARCINOMA PATIENTS BEFORE AND 3 WEEKS AFTER CHEMOTHERAPY

Haiti, Margareta and Andreano, Pillipus Resar and Putri, Yuniza Dwi (2017) THE DIFFERENCE OF HEMOGLOBIN LEVELS IN BREAST CARCINOMA PATIENTS BEFORE AND 3 WEEKS AFTER CHEMOTHERAPY. In: Seminar Nasional Kesehatan Masyarakat Sriwijaya, 28 Oktober 2017, Palembang, Sumatera Selatan.

	Image COVER PROSEDIR.jpeg Download (940kB)
	Image DAFTAR ISI HAITI.jpeg Download (1MB)
	Text JURNAL utk proseding FKM Unsri 2017.docx Download (35kB)
	Image LEMBAR ISBN.jpeg Download (194kB)

Abstract

Hemoglobin is red pigmented protein found in red blood cells that contains protein elements such as heme and globin. A hemoglobin examination is essential to know the level of a person’s anemia, especially in person with breast carcinoma before and after chemotherapy. The research is an experimental study with pretest and postest the group design. The samples were the breast carcinoma patients who were undergoing chemotherapy. Samples were taken by using an accidental sampling and 19 people were in the inclusion criteria. ). The normality test result before chemotherapy was mean ± SD (12.3±1.29) with P=0.088 (p > 0.05). The normality test result 3 weeks after chemotherapy was mean ± SD (11.9±1.33) with P=0.482. The Paired T-Test result on hemoglobin level examination before and after 3 weeks chemotherapy was mean±SD (0.37%±0.69) with percent change= 0.4% and the value of P=0.031 (p < 0.05). On the basis of this studied it can be concluded that there was a difference of hemoglobin levels in breast carcinoma patients before and 3 weeks after chemotherapy.

Actions (login required)

View Item